The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
L | Antineoplastic and immunomodulating agents | |
2
|
L01 | Antineoplastic agents | |
3
|
L01E | Protein kinase inhibitors | |
4
|
L01EH | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors | |
5
|
L01EH06 |
| Active Ingredient |
|---|
|
Sevabertinib is a reversible kinase inhibitor of human epidermal growth factor receptor 2 (HER2). It also exhibits activity against epidermal growth factor receptor (EGFR). |
| Document | Type | Information Source | |
|---|---|---|---|
| HYRNUO Film-coated tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) |